Cargando…
Case-control study about the acceptance of Pegvaliase in Phenylketonuria
INTRODUCTION: Pegvaliase is a novel enzyme substitution therapy approved by the European Drug Administration (EDA) in May 2019 for the treatment of Phenylketonuria (PKU) in adults and children ≥16 years of age. The pegylated phenylalanine ammonia lyase is isolated from bacteria and therefore provoke...
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6957785/ https://www.ncbi.nlm.nih.gov/pubmed/31956507 http://dx.doi.org/10.1016/j.ymgmr.2019.100557 |